Reactive oxygen species-induced activation of Yes-associated protein-1 through the c-Myc pathway is a therapeutic target in hepatocellular carcinoma
Yuri Cho, Min Ji Park, Koeun Kim, Sun Woong Kim, Wonjin Kim, Department of Internal Medicine, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul 06135, South Korea
Sooyeon Oh, Department of Internal Medicine, Chaum Life Center, CHA University School of Medicine, Seoul 06062, South Korea
Joo Ho Lee, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Bundang gu, South Korea
Author contributions: Cho Y designed and wrote the review, performed the literature research and interpretation and wrote the manuscript; Park MJ and Kim K performed the experiments and interpretation; Kim SW, Kim W, Oh S, Lee JH contributed to the review design, literature research, and supervised the review; all authors finally approved the manuscript.
Supported by the Research Supporting Program of the Korean Association for the Study of the Liver and The Korean Liver Foundation in 2017; and the National Research Foundation of Korea grant funded by the Korea government, No. 2018R1C1B6001102.
Institutional review board statement: All the experiments using human tissues were approved by the Bundang CHA Medical Center Institutional Review Board (CHAMC 2018-02-037). All the human tissues were provided by the Bundang CHA Biobank of Bundang CHA Medical Center. For the gene expression analyses, 88 surgically resected frozen HCC tissue samples and 88 nontumor liver tissue samples were analyzed. Cases were prospectively and consecutively identified at Bundang CHA Medical Center between 2012 and 2018.
Institutional animal care and use committee statement: The in vivo study protocol was approved by the Institutional Animal Care and Use Committee (IACUC-180027) of CHA University. All the in vivo surgical procedures were performed under anesthesia with 2,2,2-tribromoethanol, and all efforts were made to minimize suffering.
Conflict-of-interest statement: The authors declare that they do not have anything to disclose regarding any funding or conflict of interest with respect to this manuscript.
Data sharing statement: Dataset is available from the corresponding author at firstname.lastname@example.org.
ARRIVE guidelines statement: The authors have read the ARRIVE guidelines, and the manuscript was prepared and revised according to the ARRIVE guidelines.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Yuri Cho, MD, PhD, Assistant Professor, Department of Internal Medicine, CHA Gangnam Medical Center, CHA University School of Medicine, No. 569 Nonhyon-ro, Gangnam-gu, Seoul 06135, South Korea. email@example.com
Received: June 26, 2020
Peer-review started: June 26, 2020
First decision: August 22, 2020
Revised: August 27, 2020
Accepted: September 23, 2020
Article in press: September 23, 2020
Published online: November 14, 2020